OXERVATE

Dompé farmaceutici S.p.A.🇺🇸 United States

FDA Page

Effective Date: Dec 31, 2024
Approval ID: 89e4bfec-d710-40ed-8885-5d13ba46b1cd
Products: 2 registered
Version: 15

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use OXERVATE safely and effectively. See full prescribing information for OXERVATE. OXERVATE (cenegermin-bkbj) ophthalmic solution, for topical ophthalmic useInitial U.S. Approval: 2018

Quick Stats

Total Products2

Labelers2

Label Sections33

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.